Listed

Tempest Therapeutics, Inc.

TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31

Reports and events: 308 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Tempest Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2025-08-1116:13 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-106558
2025-08-1116:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-106544
2025-06-1216:18 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-139899
2025-06-1107:41 ET8-K8.01 Other events0001193125-25-138802
2025-06-0616:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-137041
2025-05-1316:31 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-070441
2025-05-1316:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-070416
2025-04-3016:05 ET10-K/AAnnual report, amendedPeriod 2024-12-310001193125-25-107127
2025-04-2809:49 ET8-K8.01 Other events0001193125-25-098817
2025-04-1816:16 ET8-K2.05 Exit or disposal costs0001193125-25-085773
2025-04-0917:26 ET8-K1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-076938
2025-04-0708:00 ET8-K3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001193125-25-073987
2025-03-2716:35 ET10-KAnnual reportPeriod 2024-12-310000950170-25-046144
2025-03-2716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-046055
2025-02-1117:58 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-018140
2024-12-3116:01 ET8-K3.01 Delisting notice0001193125-24-287170
2024-12-0616:15 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-24-272464
2024-11-1216:41 ETDEF 14AProxy statementPeriod 2024-12-030001140361-24-046210
2024-11-1216:28 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-125499
2024-11-1216:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-125444
2024-10-1007:16 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-235598
2024-08-1220:59 ETSC 13D/AOwnership report, active investor, amended0001193125-24-199144
2024-08-0816:44 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-094124
2024-08-0816:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-094102
2024-06-2008:13 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-164015
2024-06-1416:41 ET8-K5.07 Shareholder vote results0001193125-24-161685
2024-05-1316:54 ETSC 13D/AOwnership report, active investor, amended0001193125-24-137304
2024-05-0916:29 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-057072
2024-05-0916:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-057047
2024-04-2316:02 ETDEF 14AProxy statementPeriod 2024-06-130001193125-24-106959
2024-03-1916:35 ET10-KAnnual reportPeriod 2023-12-310000950170-24-033555
2024-03-1916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-033464
2024-02-0817:41 ETSC 13D/AOwnership report, active investor, amended0001193125-24-028545
2023-11-0917:28 ETSC 13D/AOwnership report, active investor, amended0001193125-23-274644
2023-11-0817:25 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061278
2023-11-0817:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-061271
2023-10-3006:06 ET8-K8.01 Other events0001193125-23-265621
2023-10-1108:13 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-253882
2023-09-0816:16 ET8-K3.01 Delisting notice0001193125-23-231557
2023-09-0716:19 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-230659
2023-08-1016:39 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041429
2023-08-1016:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-041385
2023-06-1616:22 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-23-169021
2023-05-1016:25 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-020579
2023-05-1016:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-020569
2023-05-0116:07 ETDEF 14AProxy statementPeriod 2023-06-150001193125-23-130398
2023-04-2808:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-124510
2023-03-3117:07 ET8-K8.01 Other events0001193125-23-088320
2023-03-2217:29 ET10-KAnnual reportPeriod 2022-12-310000950170-23-009237
2023-03-2217:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-009236

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.